262 related articles for article (PubMed ID: 2980556)
1. Paramagnetic enhancement of cerebral lesions with gadolinium-DTPA.
Hesselink JR; Dunn WM; Healy ME; Hajek P; Baker L; Brahme FJ
Acta Radiol Suppl; 1986; 369():558-60. PubMed ID: 2980556
[TBL] [Abstract][Full Text] [Related]
2. MR contrast enhancement of intracranial lesions with Gd-DTPA.
Hesselink JR; Press GA
Radiol Clin North Am; 1988 Jul; 26(4):873-87. PubMed ID: 3289078
[TBL] [Abstract][Full Text] [Related]
3. Benefits of Gd-DTPA for MR imaging of intracranial abnormalities.
Hesselink JR; Healy ME; Press GA; Brahme FJ
J Comput Assist Tomogr; 1988; 12(2):266-74. PubMed ID: 3351041
[TBL] [Abstract][Full Text] [Related]
4. Multicenter double-blind placebo-controlled study of gadopentetate dimeglumine as an MR contrast agent: evaluation in patients with cerebral lesions.
Russell EJ; Schaible TF; Dillon W; Drayer B; LiPuma J; Mancuso A; Maravilla K; Goldstein HA
AJR Am J Roentgenol; 1989 Apr; 152(4):813-23. PubMed ID: 2646872
[TBL] [Abstract][Full Text] [Related]
5. Gd-DTPA in MR of spinal lesions.
Valk J
AJR Am J Roentgenol; 1988 May; 150(5):1163-8. PubMed ID: 3258721
[TBL] [Abstract][Full Text] [Related]
6. Cerebral Erdheim-Chester disease: persistent enhancement with Gd-DTPA on MR images.
Tien RD; Brasch RC; Jackson DE; Dillon WP
Radiology; 1989 Sep; 172(3):791-2. PubMed ID: 2772189
[TBL] [Abstract][Full Text] [Related]
7. Extracranial lesions of the head and neck: preliminary experience with Gd-DTPA-enhanced MR imaging.
Robinson JD; Crawford SC; Teresi LM; Schiller VL; Lufkin RB; Harnsberger HR; Dietrich RB; Crim JR; Duckwiler GR; Spickler EM
Radiology; 1989 Jul; 172(1):165-70. PubMed ID: 2740499
[TBL] [Abstract][Full Text] [Related]
8. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.
Vogl TJ; Kümmel S; Hammerstingl R; Schellenbeck M; Schumacher G; Balzer T; Schwarz W; Müller PK; Bechstein WO; Mack MG; Söllner O; Felix R
Radiology; 1996 Jul; 200(1):59-67. PubMed ID: 8657946
[TBL] [Abstract][Full Text] [Related]
9. Gadolinium-DTPA enhancement of experimental soft tissue carcinoma and hemorrhage in magnetic resonance imaging.
Pettersson H; Ackerman N; Kaude J; Googe RE; Mancuso AA; Scott KN; Hackett RH; Hager DA; Caballero S
Acta Radiol; 1987; 28(1):75-8. PubMed ID: 2952147
[TBL] [Abstract][Full Text] [Related]
10. [The dynamic magnetic resonance study of focal liver lesions by FLASH sequences with bolus intravenous gadolinium-DTPA].
Olivetti L; Grazioli L; Maroldi R; Matricardi L; Milanesio L
Radiol Med; 1992 Apr; 83(4):353-60. PubMed ID: 1318558
[TBL] [Abstract][Full Text] [Related]
11. [Oral contrast media for magnetic resonance tomography of the abdomen. III. Initial patient research with gadolinium-DTPA].
Claussen C; Kornmesser W; Laniado M; Kaminsky S; Hamm B; Felix R
Rofo; 1988 Jun; 148(6):683-9. PubMed ID: 2837806
[TBL] [Abstract][Full Text] [Related]
12. [The enhancement effects of Gd-DTPA for cerebrospinal lesions-- comparison with conventional T2-weighted images].
Mano I; Yoshida H; Kono T; Tsuchida T; Terao H; Iio M
Rinsho Hoshasen; 1987 Dec; 32(13):1547-53. PubMed ID: 3448287
[No Abstract] [Full Text] [Related]
13. Gadolinium-DTPA-enhanced MR imaging of spinal neoplasms: preliminary investigation and comparison with unenhanced spin-echo and STIR sequences.
Stimac GK; Porter BA; Olson DO; Gerlach R; Genton M
AJR Am J Roentgenol; 1988 Dec; 151(6):1185-92. PubMed ID: 3055895
[TBL] [Abstract][Full Text] [Related]
14. [Gadolinium-DTPA combined with a fat suppression technique in studies with magnetic resonance at 0.5 T in soft-tissue neoplasms].
Battolla L; Zampa V; Mascalchi M; Falaschi F; Bagnolesi P; Tessa C; Paolicchi A; Bartolozzi C
Radiol Med; 1994 Oct; 88(4):353-8. PubMed ID: 7997603
[TBL] [Abstract][Full Text] [Related]
15. [The contribution of gadolinium to the magnetic resonance diagnosis of spondylodiscitis].
Dalla Palma L; Pozzi-Mucelli R; Cova M; Iannis MR; Pagnan L
Radiol Med; 1991 Oct; 82(4):393-400. PubMed ID: 1767043
[TBL] [Abstract][Full Text] [Related]
16. Is Gd-DTPA required for routine cranial MR imaging?
Elster AD; Moody DM; Ball MR; Laster DW
Radiology; 1989 Oct; 173(1):231-8. PubMed ID: 2781014
[TBL] [Abstract][Full Text] [Related]
17. [Gadolinium-DTPA as an oral contrast medium for magnetic resonance tomography of the pancreas].
Neumann K; Kaminsky S; Gogoll M; Clauss W; Langer M; Felix R
Rofo; 1991 Mar; 154(3):262-8. PubMed ID: 1849293
[TBL] [Abstract][Full Text] [Related]
18. Increased detection of intracranial metastases with intravenous Gd-DTPA.
Healy ME; Hesselink JR; Press GA; Middleton MS
Radiology; 1987 Dec; 165(3):619-24. PubMed ID: 3317496
[TBL] [Abstract][Full Text] [Related]
19. Gd-DTPA-enhanced MR imaging of pituitary macroadenomas.
Lundin P; Bergström K
Acta Radiol; 1992 Jul; 33(4):323-32. PubMed ID: 1633042
[TBL] [Abstract][Full Text] [Related]
20. [Role of Gadolinium-DTPA in the assessment of renal tumors with magnetic resonance].
Torricelli P; Montanari N; De Santis M; Pollastri C
Radiol Med; 1994 May; 87(5):653-61. PubMed ID: 8008898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
